Literature DB >> 25528636

World Urologic Oncology Federation Bladder Cancer Prevention Program: a global initiative.

Laurence Klotz1, Maurizio A Brausi2.   

Abstract

Bladder cancer is an international public health problem, and the incidence and mortality are closely tied to cigarette smoking. Urologists are, mostly, not involved in smoking cessation with their patients. The World Urologic Oncology Federation has launched a global initiative to incorporate smoking cessation into urological practice. We believe that urologists can readily be influenced to engage their patients, primary care physicians, and communities in bladder cancer prevention. The World Urologic Oncology Federation, a federation of 17 regional/national societies of urologic oncology around the world, is well positioned to lead this global effort. The results would be an extremely cost-effective program, which has the potential to substantially improve the health of the world's population.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Bladder cancer risk reduction; Prevention; Smoking cessation

Mesh:

Year:  2015        PMID: 25528636     DOI: 10.1016/j.urolonc.2014.07.017

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  12 in total

1.  The hOGG1 Ser326Cys gene polymorphism and susceptibility for bladder cancer: a meta-analysis.

Authors:  Cao Wenjuan; Lu Jianzhong; Li Chong; Gao Yanjun; Lu Keqing; Wang Hanzhang; Wang Zhiping
Journal:  Int Braz J Urol       Date:  2016-09-01       Impact factor: 1.541

2.  NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo.

Authors:  Xiaolu Cui; Dezhi Shen; Chuize Kong; Zhe Zhang; Yu Zeng; Xuyong Lin; Xiankui Liu
Journal:  Sci Rep       Date:  2017-01-31       Impact factor: 4.379

3.  The awareness of patients with non - muscle invasive bladder cancer regarding the importance of smoking cessation and their access to smoking cessation programs.

Authors:  Emrah Yuruk; Murat Tuken; Aykut Colakerol; Ege Can Serefoglu
Journal:  Int Braz J Urol       Date:  2017 Jul-Aug       Impact factor: 1.541

4.  Protein kinase C-α (PKCα) modulates cell apoptosis by stimulating nuclear translocation of NF-kappa-B p65 in urothelial cell carcinoma of the bladder.

Authors:  Jin Zheng; Chuize Kong; Xiaoxi Yang; Xiaolu Cui; Xuyong Lin; Zhe Zhang
Journal:  BMC Cancer       Date:  2017-06-19       Impact factor: 4.430

5.  The gender difference and mortality-to-incidence ratio relate to health care disparities in bladder cancer: National estimates from 33 countries.

Authors:  Shao-Chuan Wang; Wen-Wei Sung; Yu-Lin Kao; Tzuo-Yi Hsieh; Wen-Jung Chen; Sung-Lang Chen; Horng-Rong Chang
Journal:  Sci Rep       Date:  2017-06-28       Impact factor: 4.379

6.  MKP-1 overexpression is associated with chemoresistance in bladder cancer via the MAPK pathway.

Authors:  Siyu Lei; Hong Xu; Naiwen Chen; Huan Pan; Wenhua Xie; Yi He; Jing Jin
Journal:  Oncol Lett       Date:  2020-06-16       Impact factor: 2.967

7.  MicroRNA-3648 Is Upregulated to Suppress TCF21, Resulting in Promotion of Invasion and Metastasis of Human Bladder Cancer.

Authors:  Wenrui Sun; Shi Li; Yuan Yu; Honglei Jin; Qipeng Xie; Xiaohui Hua; Shuai Wang; Zhongxian Tian; Huxiang Zhang; Guosong Jiang; Chuanshu Huang; Haishan Huang
Journal:  Mol Ther Nucleic Acids       Date:  2019-04-14       Impact factor: 8.886

8.  ITPR3 facilitates tumor growth, metastasis and stemness by inducing the NF-ĸB/CD44 pathway in urinary bladder carcinoma.

Authors:  Mengzhao Zhang; Lu Wang; Yangyang Yue; Lu Zhang; Tianjie Liu; Minxuan Jing; Xiao Liang; Minghai Ma; Shan Xu; Ke Wang; Xinyang Wang; Jinhai Fan
Journal:  J Exp Clin Cancer Res       Date:  2021-02-11

9.  Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer.

Authors:  Ziyu Wu; Kun Liu; Yunyan Wang; Zongyuan Xu; Junsong Meng; Shuo Gu
Journal:  Cancer Cell Int       Date:  2015-11-14       Impact factor: 5.722

10.  Identification and validation of AIB1 and EIF5A2 for noninvasive detection of bladder cancer in urine samples.

Authors:  Bang-Fen Zhou; Jin-Huan Wei; Zhen-Hua Chen; Pei Dong; Ying-Rong Lai; Yong Fang; Hui-Ming Jiang; Jun Lu; Fang-Jian Zhou; Dan Xie; Jun-Hang Luo; Wei Chen
Journal:  Oncotarget       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.